T: iPS cells: mapping the policy issues
Amy Scott, Christopher Hyun, Insoo Bennett +9 more
Given the explosion of research on induced pluripotent stem (iPS) cells, it is timely to consider the various ethical, legal, and social issues engaged by this fast-moving field. Here, we review issues associated with the procurement, basic research, and clinical translation of iPS cells. Since the 2007 announcement that adult human skin cells can be reprogrammed to act like human embryonic stem cells (hESCs) (Takahashi et al., 2007), stem cell research has experienced renewed attention and enthusiasm from scientists, the public, patient groups, and policy makers. These new cells, called induced pluripotent stem (iPS) cells have been hailed as an ethical victory (Aalto-Setala et al., 2009 K. Aalto-Setala, B. Conklin and B. Lo, PLoS Biol. 7 (2009), p. e1000042.Aalto-Setala et al., 2009) because they represent a way of producing valuable hESC-like pluripotent stem cells without involving…